Page 159 - 南京医科大学自然版

第45卷第6期 成永奇，陈乐延，郑明峰. ⅠA期肺腺癌预后高危影响因素及术后辅助治疗的研究进展［J］.
2025年6月 南京医科大学学报（自然科学版），2025，45（6）：891-899 ·897 ·

［3］ RIELY G J，WOOD D E，ETTINGER D S，et al. Non ⁃ multicenter study［J］. J Thorac Oncol，2016，11（7）：
small cell lung cancer，version 4.2024，NCCN clinical 1012-1028
practice guidelines in oncology［J］. J Natl Compr Canc ［14］MAO R，SHE Y L，ZHU E J，et al. A proposal for resta⁃
Netw，2024，22（4）：249-274 ging of invasive lung adenocarcinoma manifesting as pure
［4］ PISTERS K，KRIS M G，GASPAR L E，et al. Adjuvant ground glass opacity［J］. Ann Thorac Surg，2019，107
systemic therapy and adjuvant radiation therapy for stage （5）：1523-1531
Ⅰ⁃ⅢA completely resected non⁃small⁃cell lung cancer： ［15］SUZUKI K，KOIKE T，ASAKAWA T，et al. A prospective
ASCO guideline rapid recommendation update［J］. J Clin radiological study of thin ⁃ section computed tomography
Oncol，2022，40（10）：1127-1129 to predict pathological noninvasiveness in peripheral
［5］ RAMI⁃PORTA R，NISHIMURA K K，GIROUX D J，et al. clinicalⅠA lung cancer（Japan Clinical Oncology Group
The international association for the study of lung cancer 0201）［J］. J Thorac Oncol，2011，6（4）：751-756
lung cancer staging project：proposals for revision of the ［16］ ASAMURA H，HISHIDA T，SUZUKI K，et al. Radio⁃
TNM stage groups in the forthcoming（ninth）edition of graphically determined noninvasive adenocarcinoma of
the TNM classification for lung cancer［J］. J Thorac Oncol， the lung：survival outcomes of Japan Clinical Oncology
2024，19（7）：1007-1027 Group 0201［J］. J Thorac Cardiovasc Surg，2013，146
［6］ HATTORI A，SUZUKI K，TAKAMOCHI K，et al. Prog⁃ （1）：24-30
nostic impact of a ground⁃glass opacity component in clini⁃ ［17］LAI J L，LI Q，FU F Q，et al. Subsolid lung adenocarcino⁃
cal stageⅠA non⁃small cell lung cancer［J］. J Thorac mas：radiological，clinical and pathological features and
Cardiovasc Surg，2021，161（4）：1469-1480 outcomes［J］. Semin Thorac Cardiovasc Surg，2022，34
［7］ LIN H H，PENG Z Y，ZHOU K，et al. Differential efficacy （2）：702-710
of segmentectomy and wedge resection in sublobar resec⁃ ［18］ WATANABE Y，HATTORI A，NOJIRI S，et al. Clinical
tion compared to lobectomy for solid⁃dominant stageⅠA impact of a small component of ground⁃glass opacity in
lung cancer：a systematic review and meta ⁃ analysis［J］. solid ⁃ dominant clinical stage Ⅰ A non ⁃ small cell lung
Int J Surg，2024，110（2）：1159-1171 cancer［J］. J Thorac Cardiovasc Surg，2022，163（3）：
［8］ LIN L，HU D Z，ZHONG C X，et al. Safety and efficacy of 791-801
thoracoscopic wedge resection for elderly high ⁃ risk ［19］FU F Q，ZHANG Y，WEN Z X，et al. Distinct prognostic
patients with stage Ⅰ peripheral non ⁃ small ⁃ cell lung factors in patients with stageⅠnon⁃small cell lung cancer
cancer［J］. J Cardiothorac Surg，2013，8：231 with radiologic part⁃solid or solid lesions［J］. J Thorac On⁃
［9］ KAMIGAICHI A，MIMAE T，TSUBOKAWA N，et al. col，2019，14（12）：2133-2142
Wedge resection is an acceptable treatment option for ［20］HATTORI A，SUZUKI K，MATSUNAGA T，et al. Visceral
radiologically low⁃grade lung cancer with solid predomi⁃ pleural invasion is not a significant prognostic factor in
nance［J］. Interdiscip Cardiovasc Thorac Surg，2023，36 patients with a part ⁃ solid lung cancer［J］. Ann Thorac
（1）：ivac285 Surg，2014，98（2）：433-438
［10］ XI J J，YIN J C，LIANG J Q，et al. Prognostic impact of ［21］SUZUKI K，WATANABE S I，WAKABAYASHI M，et al.
radiological consolidation tumor ratio in clinical stageⅠA A single⁃arm study of sublobar resection for ground⁃glass
pulmonary ground glass opacities［J］. Front Oncol，2021， opacity dominant peripheral lung cancer［J］. J Thorac
11：616149 Cardiovasc Surg，2022，163（1）：289-301
［11］ ZHAI W Y，GONG L，ZHENG Y Z，et al. Ground glass ［22］ AOKAGE K，SUZUKI K，SAJI H，et al. Segmentectomy
opacity and adjuvant chemotherapy in pathological stage for ground⁃glass⁃dominant lung cancer with a tumour
ⅠB⁃ⅡA lung adenocarcinoma［J］. Front Oncol，2022， diameter of 3 cm or less including ground⁃glass opacity
12：851276 （JCOG1211）：a multicentre，single ⁃ arm，confirmatory，
［12］KATSUMATA S，AOKAGE K，ISHII G，et al. Pathologi⁃ phase 3 trial［J］. Lancet Respir Med，2023，11（6）：540-
cal features and prognostic implications of ground⁃glass 549
opacity components on computed tomography for clinical ［23］ SAJI H，OKADA M，TSUBOI M，et al. Segmentectomy
stage Ⅰ lung adenocarcinoma［J］. Surg Today，2021，51 versus lobectomy in small ⁃ sized peripheral non ⁃ small ⁃
（7）：1188-1202 cell lung cancer（JCOG0802/WJOG4607L）：a multicentre，
［13］KAKINUMA R，NOGUCHI M，ASHIZAWA K，et al. Natural open⁃label，phase 3，randomised，controlled，non⁃inferio⁃
history of pulmonary subsolid nodules：a prospective rity trial［J］. Lancet，2022，399（10335）：1607-1617